CYTOKINETICS INC

CYTK - CIK 0001061983

Market cap$8.35 B

Rank#1044

SEC filings2,450

CYTOKINETICS INC trades as CYTK and has a market capitalization of $8.35 B, making it the #1044 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $88.04M, up 376.6% from the prior year and net income of -$784.96M. This page tracks CYTOKINETICS INC through 2,450 SEC filings, with financial statements and metrics updated as new reports are filed.

Key metrics

Revenue (latest FY)$88.04MFY 2025

Net income (latest FY)-$784.96MFY 2025

Operating cash flow (latest FY)-$510.01MFY 2025

Total assets (latest FY)$1.42BFY 2025

Net margin-891.6%latest FY

Financial performance

Over the last 9 fiscal years CYTOKINETICS INC's revenue declined from $106.41M to $88.04M, a compound annual decline rate of 2.1%. Net profit margin compressed from 15.5% to -891.6% over the same period - every figure below comes from the company's audited annual filings.

CYTK annual revenueView details

Key statistics

Market cap: $8.35 B
Share price (derived)market cap / shares outstanding: $67.07
EPS (diluted)FY 2025: $-6.54
Shares outstandingas of 2026-05-04: 0.12B
Total equityas of 2024-06-30: $108.55M
Return on equity: -723.1%
Long-term debtas of 2026-03-31: $247.21M
Cash & equivalentsas of 2026-03-31: $129.84M

Latest filings

Filing	Type	Filed
Insider trade	4	2026-05-20
Insider trade	4	2026-05-14
Major company event	8-K	2026-05-08
Prospectus supplement	424B5	2026-05-07
SCHEDULE 13G/A	-	2026-05-06
Insider sale notice	144	2026-05-05
Insider sale notice	144	2026-05-05
Insider sale notice	144	2026-05-05

Browse the full filing history (2,450 filings)

Recent press releases

View All Press Releases2026-05-20
Cytokinetics to Hold Annual Meeting of Stockholders
View All Press Releases2026-05-18
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
View All Press Releases2026-05-14
Cytokinetics to Host Annual Symposium on Contemporary Landscapes in Muscle Biology (CLIMB)
View All Press Releases2026-05-12
Cytokinetics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
View All Press Releases2026-05-11
Cytokinetics Announces New Data Related to MYQORZO® (aficamten) at ESC Heart Failure 2026

Similar companies

The largest companies sharing CYTOKINETICS INC's SEC industry classification (pharmaceutical preparations).

LLYEli Lilly and Company$1.072 T CYTK vs LLY

JNJJohnson & Johnson$573.98 B CYTK vs JNJ

ABBVAbbVie Inc.$399.47 B CYTK vs ABBV

MRKMerck & Co., Inc.$293.16 B CYTK vs MRK

AZNAstraZeneca PLC$286.27 B CYTK vs AZN

Frequently asked questions

What is CYTOKINETICS INC's market cap?

CYTOKINETICS INC (CYTK) has a market capitalization of $8.35 B as of 2026-06-10, ranking #1044 among US-listed companies.

How much revenue does CYTOKINETICS INC make?

CYTOKINETICS INC reported revenue of $88.04M for fiscal year 2025, an increase of 376.6% year over year.

Is CYTOKINETICS INC profitable?

In its latest fiscal year CYTOKINETICS INC reported a net loss of $784.96M.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.